Species | Disease models | Targeted organs | Mitochondrial sources | Transplantation methods and timings | Immune response-related outcomes | Refs. |
---|---|---|---|---|---|---|
New Zealand white rabbits (male) | Focal ischemia | Heart | Autograft: Pectoralis major muscle | Direct injection 8 times, 1Â min before reperfusion | No significant increase in serum inflammatory markers, No anti-mitochondrial antibodies in serum | [80] |
Yorkshire pigs (female) | Focal ischemia | Heart | Autograft: Pectoralis major muscle | Direct injection 8 times, 1Â min before reperfusion | No significant increase in serum cytokines | [81] |
Wistar rats (male) | Focal ischemia | Heart | Allograft: Muscle | Direct injection, upon reperfusion | Modulated autophagic activity, decreased pro-inflammatory cytokines | [71] |
1) Wistar rats 2) patient-derived hLCLs | 1) Poly I:C MIA 2) Schizophrenia | 1) Brain 2) Cell | 1) Allograft: Brain 2) hLCLs | 1) IC 2) Co-culture | MTx to Poly I:C MIA showed improved immune balance MTx to healthy hLCLs exhibited immune imbalance, and stress-related chemokine release | [79] |
ICR mice (male) | Depression | Brain | Allograft: Hippocampus | IV, upon or 6Â h after LPS injection | Decreased oxidative stress and inflammatory cytokine levels, improved mood-related behavior | [75] |
SD rats | Focal ischemia | Spinal cord | Allograft: Soleus muscle | Direct injection 2 times, Following SCI | Alleviated cellular apoptosis and inflammation responses | [72] |
SD rats (male) | Tendinopathy | Tendon | Allograft: L6 rat myoblast cell lines | Direct injection, 2Â weeks after collagenase injection | Reduced inflammation, and apoptosis; Decreased pro-inflammatory cytokines, increased anti-inflammatory cytokines | [76] |
SD rats (male) | Osteoarthritis | Knee joint | BMSCs from tibia and femur | Direct injection into joint cavity, Once a week for 6Â weeks | Increased the production of ATP, inhibited apoptosis, and decreased the production of ROS | [77] |
C57BL/6 mice (male) | Sepsis | Whole body | Allograft: Pectoralis major muscle | IV (tail vein), 120Â min after CLP | Reduced inflammation, enhanced bacterial clearance, decreased pro-inflammatory cytokines, and increased anti-inflammatory cytokines | [69] |
BALB/C mice (male) | Sepsis | Whole body | UC-MSCs | IV, upon or 30 min after LPS injection | Inhibited the LPS-induced production of pro-inflammatory cytokines/ chemokines, Inhibited the NFκB signaling pathway | [78] |